The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Women with hypertrophic cardiomyopathy have worse survival
Open accessAbstract
AIMS: Sex differences in hypertrophic cardiomyopathy (HCM) remain unclear. We sought to characterize sex differences in a large HCM referral centre population. METHODS AND RESULTS: Three thousand six hundred and seventy-three adult patients with HCM underwent evaluation between January 1975 and September 2012 with 1661 (45.2%) female. Kaplan-Meier survival curves were assessed via log-rank test. Cox proportional hazard regression analyses evaluated the relation of sex with survival. At index visit, women were older (59 ± 16 vs. 52 ± 15 years, P < 0.0001) had more symptoms [New York Heart Association (NYHA) Class III-IV 45.0% vs. 35.3%, P < 0.0001], more obstructive physiology (77.4% vs. 71.8%, P = 0.0001), more mitral regurgitation (moderate or greater in 56.1% vs. 43.9%, P < 0.0001), higher E/e' ratio (n = 1649, 20.6 vs. 15.6, P < 0.0001), higher estimated pulmonary artery systolic pressure (n = 1783, 40.8 ± 15.4 vs. 34.8 ± 10.8 mmHg, P < 0.0001), worse cardiopulmonary exercise performance (n = 1267; percent VO2 predicted 62.8 ± 20% vs. 65.8 ± 19.2%, P = 0.007), and underwent more frequent alcohol septal ablation (4.9% vs. 3.0%, P = 0.004) but similar frequency of myectomy (28% vs. 30%, P = 0.24). Median follow-up was 10.9 (IQR 7.4-16.2) years. Kaplan-Meier analysis demonstrated lower survival in women compared with men (P < 0.0001). In multivariable modelling, female sex remained independently associated with mortality (HR 1.13 [1.03-1.22], P = 0.01) when adjusted for age, NYHA Class III-IV symptoms, and cardiovascular comorbidities. CONCLUSION: Women with HCM present at more advanced age, with more symptoms, worse cardiopulmonary exercise tolerance, and different haemodynamics than men. Sex is an important determinant in HCM management as women with HCM have worse survival. Women may require more aggressive diagnostic and therapeutic approaches.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lang, R. M., Bierig, M., Devereux, R. B., Flachskampf, F. A., Foster, E., Pellikka, P. A., Picard, M. H., Roman, M. J., Seward, J., Shanewise, J. S., et al. (2005) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2005.10.005 · Cited by 11,318
2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy
Authors/Task Force members, Elliott, P. M., Anastasakis, A., Borger, M. A., Borggrefe, M., Cecchi, F., Charron, P., Hagege, A. A., Lafont, A., Limongelli, G., et al. (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu284 · Cited by 4,332
New-Onset Atrial Fibrillation: Sex Differences in Presentation, Treatment, and Outcome
Humphries, K. H., Kerr, C. R., Connolly, S. J., Klein, G., Boone, J. A., Green, M., Sheldon, R., Talajic, M., Dorian, P., & Newman, D. (2001) · Circulation · doi:10.1161/01.cir.103.19.2365 · Cited by 378
Cited by
Clinical Course and Management of Hypertrophic Cardiomyopathy
Maron, B. J. (2018) · New England Journal of Medicine · doi:10.1056/nejmra1710575 · Cited by 944
Ko, W.-Y., Siontis, K. C., Attia, Z. I., Carter, R. E., Kapa, S., Ommen, S. R., Demuth, S. J., Ackerman, M. J., Gersh, B. J., Arruda-Olson, A. M., et al. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.12.030 · Cited by 404
Self-citationGeske, J. B., Ommen, S. R., & Gersh, B. J. (2018) · JACC: Heart Failure · doi:10.1016/j.jchf.2018.02.010 · Cited by 311
Self-citationCui, H., Schaff, H. V., Wang, S., Lahr, B. D., Rowin, E. J., Rastegar, H., Hu, S., Eleid, M. F., Dearani, J. A., Kimmelstiel, C., et al. (2022) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2022.02.032 · Cited by 113
Self-citationObstruction in Hypertrophic Cardiomyopathy: Many Faces
Abbasi, M., Ong, K. C., Newman, D. B., Dearani, J. A., Schaff, H. V., & Geske, J. B. (2024) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2024.02.010 · Cited by 49
Self-citation
Metadata
- Authors
- Geske, J. B., Ong, K. C., Siontis, K. C., Hebl, V. B., Ackerman, M. J., Hodge, D. O., Miller, V. M., Nishimura, R. A., Oh, J. K., Schaff, H. V., Gersh, B. J., & Ommen, S. R.
- Venue
- European Heart Journal
- Publisher
- Oxford University Press (OUP)
- Published
- 2017-09-08
- Volume
- 38
- Issue
- 46
- Pages
- 3434-3440
- ISSN
- 0195-668X (ISSN-L)
- 1522-9645
- OpenAlex
- W2752291901
- Cited by
- 225
- References
- 4
- FWCI
- 11.60
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Women with hypertrophic cardiomyopathy have worse survival. https://app.cochat.ai/papers/10.1093/eurheartj/ehx527
- The paper
- Geske, J. B., Ong, K. C., Siontis, K. C., Hebl, V. B., Ackerman, M. J., Hodge, D. O., Miller, V. M., Nishimura, R. A., Oh, J. K., Schaff, H. V., Gersh, B. J., & Ommen, S. R. (2017). Women with hypertrophic cardiomyopathy have worse survival. European Heart Journal. https://doi.org/10.1093/eurheartj/ehx527
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.